Cardio Diagnostics 

$1.94
0
+$0.2+11.49% Today

Statistics

Day High
1.95
Day Low
1.74
52W High
-
52W Low
-
Volume
72
Avg. Volume
-
Mkt Cap
3.54M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3JunExpected
Q3 2025
Q4 2025
Next
-1.8
-1.47
-1.13
-0.8
Expected EPS
N/A
Actual EPS
N/A

Financials

-23,951.43%Profit Margin
Unprofitable
2021
2022
2023
2024
70,000Revenue
-16.77MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CDIO.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a broad range of diagnostics products, including cardiovascular diagnostics, competing directly with Cardio Diagnostics' offerings.
Quest Diagnostics
DGX
Mkt Cap19.57B
Quest Diagnostics provides diagnostic testing for conditions including heart diseases, making it a competitor in the cardiovascular diagnostics market.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers products and services for diagnostics, including cardiovascular health, competing in the same space as Cardio Diagnostics.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories provides clinical diagnostics products, including those for cardiovascular disease, directly competing with Cardio Diagnostics.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation's diagnostics segment includes products for cardiovascular health, making it a competitor to Cardio Diagnostics.
Labcorp
LH
Mkt Cap21.08B
Laboratory Corporation of America offers a range of diagnostic tests, including for cardiovascular conditions, competing with Cardio Diagnostics.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation specializes in medical devices for conditions including heart diseases, indirectly competing with Cardio Diagnostics by offering alternative diagnostic solutions.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc offers medical devices for diagnosing and treating heart conditions, providing an alternative approach to Cardio Diagnostics' solutions.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. provides diagnostics products and services, including for cardiovascular health, making it a competitor in the diagnostics market.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies provides laboratories worldwide with instruments, services, consumables, applications, and expertise, including in cardiovascular diagnostics, competing with Cardio Diagnostics.

About

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Show more...
CEO
ISIN
US14159C2026

Listings

0 Comments

Share your thoughts

FAQ

What is Cardio Diagnostics stock price today?
The current price of CDIO.BOATS is $1.94 USD — it has increased by +11.49% in the past 24 hours. Watch Cardio Diagnostics stock price performance more closely on the chart.
What is Cardio Diagnostics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cardio Diagnostics stocks are traded under the ticker CDIO.BOATS.
What is Cardio Diagnostics market cap?
Today Cardio Diagnostics has the market capitalization of 3.54M
When is the next Cardio Diagnostics earnings date?
Cardio Diagnostics is going to release the next earnings report on June 03, 2026.
What is Cardio Diagnostics revenue for the last year?
Cardio Diagnostics revenue for the last year amounts to 70,000 USD.
What is Cardio Diagnostics net income for the last year?
CDIO.BOATS net income for the last year is -16.77M USD.
When did Cardio Diagnostics complete a stock split?
Cardio Diagnostics has not had any recent stock splits.